BioMark Diagnostics Inc.
BMKDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$50.05M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $50.05 Million |
|---|---|
| Enterprise Value | $50.59 Million |
| Earnings per Share | $-0.01 |
| Beta | -0.31 |
| Outstanding Shares | 106,357,472 |
Return
| Return on Equity | -249.56% |
|---|---|
| Return on Assets | -65.79% |
| Return on Invested Capital | -123.67% |
Valuation & Multiples
| P/E Ratio | -34.81 |
|---|---|
| PEG | 280.12 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1819.53 |
| Enterprise Value to EBIT | -27.29 |
| Enterprise Value to Net Income | -36 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 2.23 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioMark Diagnostics Inc.
9 employees
CEO: Rashid Ahmed Maula Bux
BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial...